Information about Igma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0656.484.221

VAT liability
Yes
Established
08-06-2016
Last balance sheet year
2025
Company size
Micro 0 FTE
Principal activity
General construction of residential buildings
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Igma

2025 2024 2023 2022
Profit/Loss 53,795 602,93% 7,653 -42,01% 13,197 19,73% 11,022
Equity 74,255 -29,83% 105,823 7,8% 98,170 15,53% 84,973
Gross margin 71,833 208,79% 23,263 1,06% 23,018 -17,15% 27,784

Publications from Igma

Date Publication
20-12-2024 Articles of Association (Translation, Coordination, Other Modifications, …) - Goal - Resignations - Appointments - General meeting (NL)
28-12-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Registered Office - Resignations - Appointments (NL)
10-06-2016 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Igma?
The VAT number of Igma is BE 0656.484.221.
Wat is the PEPPOL ID of Igma?
The PEPPOL ID of Igma is 0208:0656484221. Log in or start a free trial to see the full overview.
When was Igma founded?
Igma was founded on 08-06-2016.
What is the address of Igma?
The current registered office of Igma is located at Kloosterstraat 28, 9255 Buggenhout.
When was the last time Igma filed their annual financial statements?
The most recent financial statements of Igma were filed on 27-06-2026.
How many employees does Igma have?
There are currently no employees working at Igma or no workforce information is available.
What is the annual turnover of Igma?
At the time of its most recent financial statements, Igma did not publish any turnover figures. Igma reported a gross margin of €71,833.13.